Evidence map›Paper›PMID 42031167›Full record

ArticleThe Journal of biological chemistry2026

Ngt-1: A glycosyltransferase that confers resistance to three distinct antibiotic classes.

Amna Abbas, David Sychantha, Kalinka Koteva, Mei Chiao, Akosiererem Sokaribo, Dirk Hackenberger, Sara Andres, Gerard D Wright

Abstract read
In one paragraph

Article in The Journal of biological chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Amna AbbasDepartment of Biochemistry and Biomedical Sciences, David Braley Centre for Antibiotic Discovery, M.G. DeGroote Institute for Infectious Disease Research, McMaster University, Hamilton, Ontario, Canada.
David SychanthaDepartment of Biochemistry and Biomedical Sciences, David Braley Centre for Antibiotic Discovery, M.G. DeGroote Institute for Infectious Disease Research, McMaster University, Hamilton, Ontario, Canada; Department of Chemistry, University of Waterloo, Waterloo, Ontario, Canada.
Kalinka KotevaDepartment of Biochemistry and Biomedical Sciences, David Braley Centre for Antibiotic Discovery, M.G. DeGroote Institute for Infectious Disease Research, McMaster University, Hamilton, Ontario, Canada.
Mei ChiaoDepartment of Biochemistry and Biomedical Sciences, David Braley Centre for Antibiotic Discovery, M.G. DeGroote Institute for Infectious Disease Research, McMaster University, Hamilton, Ontario, Canada.
Akosiererem SokariboDepartment of Biochemistry and Biomedical Sciences, David Braley Centre for Antibiotic Discovery, M.G. DeGroote Institute for Infectious Disease Research, McMaster University, Hamilton, Ontario, Canada.
Dirk HackenbergerDepartment of Biochemistry and Biomedical Sciences, David Braley Centre for Antibiotic Discovery, M.G. DeGroote Institute for Infectious Disease Research, McMaster University, Hamilton, Ontario, Canada.
Sara AndresDepartment of Biochemistry and Biomedical Sciences, David Braley Centre for Antibiotic Discovery, M.G. DeGroote Institute for Infectious Disease Research, McMaster University, Hamilton, Ontario, Canada.
Gerard D WrightDepartment of Biochemistry and Biomedical Sciences, David Braley Centre for Antibiotic Discovery, M.G. DeGroote Institute for Infectious Disease Research, McMaster University, Hamilton, Ontario, Canada. Electronic address: wrightge@mcmaster.ca.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Environmental microbes are a rich source of antibiotic resistance genes with the potential to be mobilized and captured by pathogens under selective pressure. This largely unexplored resistome offers an opportunity to identify novel resistance mechanisms that may eventually emerge in clinical settings, supporting efforts to maintain current antibiotic efficacy. From a screen of environmental bacterial isolates, we identified Bacillus thuringiensis WAC10774 B, which confers resistance to the aminocoumarin antibiotic novobiocin through enzymatic inactivation. Analysis of the inactive antibiotic revealed that WAC10774 B modifies novobiocin via glycosylation, a unique transformation not reported since the antibiotic's discovery 70 years ago. Using activity-guided protein purification, we identified the novobiocin glycosyltransferase, Ngt-1, and its encoding gene. Surprisingly, ngt-1 confers resistance to three structurally distinct antibiotic classes: novobiocin (aminocoumarin), fidaxomicin (tiacumicin), and salinomycin (polyether). To further explore Ngt-1's functional breadth, we performed steady-state kinetic and protein-structure studies, revealing Ngt-1 as a novel, broad-spectrum glycosyltransferase capable of inactivating antibiotics. These findings highlight the importance of exploring the environmental resistome to identify new resistance enzymes and to inform strategies to combat antimicrobial resistance.

Indexed as

Anti-Bacterial AgentsBacillus thuringiensisDrug Resistance, BacterialGlycosyltransferasesNovobiocinAnti-Bacterial AgentsGlycosyltransferasesNovobiocinantibioticsdrug inactivationenzyme mechanismglycosyltransferaseresistance

Identifiers

PMID42031167
PMCPMC13214531

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.